Prophylactic Use of Enoxaparin in Morbidly Obese Adolescents During Bariatric Surgery.

Trial Profile

Prophylactic Use of Enoxaparin in Morbidly Obese Adolescents During Bariatric Surgery.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 14 Feb 2017

At a glance

  • Drugs Enoxaparin sodium (Primary)
  • Indications Thrombosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 09 Feb 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Jun 2017.
    • 26 Jul 2016 Status changed from recruiting to active, no longer recruiting.
    • 04 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top